Home/Filings/4/0001628280-25-012364
4//SEC Filing

FOUSE JACQUALYN A 4

Accession 0001628280-25-012364

CIK 0001157601other

Filed

Mar 11, 8:00 PM ET

Accepted

Mar 12, 4:29 PM ET

Size

7.2 KB

Accession

0001628280-25-012364

Insider Transaction Report

Form 4
Period: 2025-03-10
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-03-10+1,5791,579 total
    Exercise: $329.16Exp: 2035-03-10Common Stock (1,579 underlying)
  • Award

    Common Stock

    2025-03-10+894894 total
Footnotes (2)
  • [F1]Represents a grant of restricted stock units, which vest as to 50% of the shares on each of March 10, 2026 and March 10, 2027, provided the Reporting Person continues in service with the Issuer on each such date.
  • [F2]The option vests as to 50% of the shares on the first anniversary of the date of grant (March 10, 2026) and, thereafter, 12.5% of the shares shall vest on the last day of each successive three-month period, provided the Reporting Person continues in service with the Issuer on each such date.

Issuer

MADRIGAL PHARMACEUTICALS, INC.

CIK 0001157601

Entity typeother

Related Parties

1
  • filerCIK 0001405288

Filing Metadata

Form type
4
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 4:29 PM ET
Size
7.2 KB